As the trial date approaches for a significant foreign bribery case involving alleged corrupt activities by U.S. businessmen in India, New Jersey’s Acting U.S. Attorney, John Giordano, has requested an additional review. This move comes despite the Department of Justice (DOJ) previously allowing the case to proceed, even under a Trump administration directive that had temporarily halted enforcement of foreign bribery cases.
The trial, now scheduled for March 17, was initially delayed due to an unspecified medical issue. Giordano, who has been in his current role since March 3, is advocating for a 180-day pause to conduct a more exhaustive evaluation of the case’s details. The decision has injected a degree of uncertainty into proceedings that were advancing towards trial.
This development adds complexity to the DOJ’s ongoing management of foreign bribery cases, particularly in light of the halted measures from the previous administration. The case has drawn attention due to the contrast between the DOJ’s previous green light and the current push for a pause. For further details on this evolving story, refer to the Bloomberg Law report.